Key facts
- Ralph Smalling, head of regulatory at Genelux, sold stock.
- The value of the stock sold was $562.
- The transaction was reported to the SEC.
Ralph Smalling, who holds the position of head of regulatory at Genelux, has sold shares of the company's stock. The total value of the transaction amounted to $562. This stock sale was officially reported to the U.S. Securities and Exchange Commission (SEC), as required for insider transactions.